Ranolazine effectively improves clinical symptoms in patients with slow flow coronary arteries: a randomized, double-blind, placebo-controlled clinical trial

Ranolazine Coronary arteries
DOI: 10.1007/s00210-024-03746-9 Publication Date: 2025-01-15T11:38:58Z